Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,083 total articles
Director Kamal Ghaffarian, who holds a 10% ownership stake in Intuitive Machines, Inc., executed a sale of approximately $4.86 million in Class A Common Stock on May 18, 2026. This transaction was carried out through an established Rule 10b5-1 trading plan. The sales occur as the company's stock price trades near its 52-week high but has recently f…
Luke Evnin, a director at Werewolf Therapeutics, Inc., sold approximately 171,049 shares of common stock between May 18 and May 20, 2026. These transactions generated proceeds of roughly $76,363. The sales occurred during a period of significant market weakness for the stock, which had declined nearly 25% in the preceding week and was trading near …
Cadence Design Systems' Senior Vice President Paul Scannell executed multiple stock sales in May 2026. These transactions occurred while the company traded near its 52-week high, prompting observations regarding current valuation levels. Despite the insider selling activity, Cadence has received positive analyst coverage following strong first and …
Executive Vice President Mark Brosius executed multiple sales of Intuitive Surgical Inc. common stock between May 18 and May 20, 2026. These transactions were conducted under a pre-arranged trading plan (Rule 10b5-1). The sale occurred while the company's shares are near their 52-week low. This insider activity is noted alongside recent positive an…
Charles Lacey III Compton, CEO of Fastly, Inc., executed two separate sales of company Class A Common Stock in May 2026, totaling $764,339. This activity occurred against a backdrop of the company reporting strong first-quarter financial results for 2026, though the stock experienced notable declines both after and before market close.
Fastly, Inc.'s Chief Financial Officer, Richard Wong, executed two separate sales of company stock in May 2026. These transactions occurred shortly after Fastly reported strong first-quarter financial results and experienced subsequent declines in stock value, raising questions about internal confidence despite positive operational metrics.
President Scott R. Lovett sold a portion of his Fastly shares, totaling $250,104. This transaction occurred against a backdrop of strong first-quarter financial performance for the company and concurrent market fluctuations. The Q1 2026 results showed an earnings per share (EPS) beat and increased revenue.
Heartflow, Inc.'s Chief Medical Officer, Campbell Rogers, engaged in significant common stock sales following the exercise of options. This activity occurred while the company reported a strong first quarter 2026, with revenues rising 41% to $52.6 million and earnings per share (EPS) beating estimates. However, despite the positive financial report…
Director James R. Groch of WEX Inc. acquired 1,500 shares on May 18, 2026, totaling $214,424. This insider activity occurs against a backdrop of positive corporate developments for the payment solutions company. WEX recently reported first-quarter results that surpassed both earnings and revenue projections. Furthermore, the board authorized a subs…
Director Bob R Simpson, a major shareholder and general partner representative at TXO Partners, L.P., executed two separate transactions totaling the acquisition of 148,403 common units valued at approximately $1.97 million. This insider buying activity occurs while the stock trades at $13.23, with analysts maintaining bullish price targets and not…
A recent transaction involving a director of Tredegar Corp (NYSE:TG) noted the sale of company stock. Separately, the corporation and its subsidiary, Bonnell Aluminum, reported significant internal leadership transitions following the Annual Meeting of Shareholders, including the retirement of a long-serving executive and the appointment of new sen…
Global GP LLC, the general partner for GLOBAL PARTNERS LP (NASDAQ:GLP), executed significant purchases of limited partner units between May 18 and May 20, 2026. This insider buying occurs while GLP shares have risen substantially year-to-date. The activity is linked to fulfilling obligations under the Global Partners LP Long-Term Incentive Plan. Fu…
Director Shelleye Archambeau sold 2,500 shares of Okta's Class A Common Stock on May 18, 2026. This transaction was conducted via a Rule 10b5-1 trading plan. Despite the sale, the company remains central to positive analyst coverage, with multiple firms upgrading ratings and raising price targets due to strong demand for identity security solutions…
Senior Vice President Paul Scannell recently executed two transactions selling shares of Cadence Design Systems Inc. (CDNS) common stock. These insider actions occur against a backdrop of positive analyst sentiment, including price target increases from BofA Securities and KeyBanc, alongside key corporate developments like the acquisition of Hexago…
Daniel T. Sweeney, Executive Vice President, General Counsel, and Corporate Secretary at Prairie Operating Co. (NASDAQ:PROP), recently acquired shares of the company's common stock on May 19, 2026. This purchase occurred as PROP's shares trade near their 52-week low of $0.77, having declined substantially over the last year. The company is also nav…
Kathleen Ford, Chief Operating Officer of Kura Oncology (NASDAQ:KURA), executed a sale of company stock totaling $20,482. This transaction occurred despite the underlying stock experiencing significant gains over the past year and in the most recent week. The selling was conducted through an established Rule 10b5-1 trading plan. Separately, Kura On…
Nelson Griggs, president of Capital Access Platforms at NASDAQ, Inc., recently sold a significant amount of company stock. This transaction occurs against a backdrop of various corporate activities, including SpaceX's planned listing on Nasdaq, the introduction of prediction markets for private companies, and an increase in reported short interest …
Freshpet, Inc.'s recent financial performance has drawn significant attention from investors and analysts. This focus is compounded by a notable transaction involving one of the company's directors, suggesting internal confidence amid fluctuating market sentiment. The report details director Jacki Sue Kelley's acquisition of shares and reviews Fres…
Rajiv A. Tata, a Vice President, General Counsel, and Corporate Secretary at Ducommun Inc., sold 1,612 shares of common stock valued at $233,740 on May 20, 2026. This transaction was specifically required to satisfy obligations under the company's Second Amended and Restated Clawback Policy, which was triggered by revisions to previously issued fin…
StoneX Group's Chief Governance/Legal Officer, Diego Rotsztain, recently sold a total of approximately $3.78 million worth of company stock over May 18 and May 20, 2026. These sales occurred after the officer acquired shares through the exercise of stock options. Separately, the company reported its second quarter financial results for fiscal year …
Michael Stock, Chief Financial Officer of Liberty Energy Inc., executed a planned sale of shares on May 20, 2026. This insider activity takes place while the stock is trading near its 52-week high, following robust financial reporting for Q1 2026 and positive analyst commentary regarding the company's market positioning.
Atara Biotherapeutics CEO AnhCo Nguyen sold a portion of his holdings in the company. This transaction occurred while the firm was advancing its biologics license application for tabelecleucel. The FDA provided guidance suggesting that a single-arm study with historical controls could suffice for safety and efficacy data, and Freedom Broker upgrade…
Atara Biotherapeutics' Chief Accounting Officer, Yanina Grant-Huerta, executed a stock sale valued at $22,036. This transaction occurred as the company's shares have seen declines recently, while simultaneously receiving positive updates regarding the resubmission of its biologics license application for tabelecleucel.
The Chief Executive Officer of KORU Medical Systems, Inc., Linda M. Tharby, recently acquired additional common stock in the company. This insider transaction occurs amid positive recent news regarding the firm's financial performance and technological advancements. Specifically, KRMD reported strong first-quarter revenue figures that surpassed ana…
Axcelis Technologies director Gregory B. Graves sold a total value of $456,697 worth of common stock on May 19, 2026. The transaction occurred against a backdrop of mixed company performance, as ACLS reported first-quarter earnings that missed analyst expectations but maintained its full-year sales guidance.
